Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarkers in QuantiFERON Supernatants May Help Distinguish Latent Tuberculosis Infection From Active Tuberculosis: Preliminary Report.

Mediators of inflammation·2026
Same author

Alarming levels of fluoroquinolone resistance among MDR-TB patients in Poland: molecular and phenotypic analysis.

Frontiers in cellular and infection microbiology·2026
Same author

Catalytic and Antitubercular Activities of Multifunctional Copper(II)-Schiff Base Complexes: Insights into Structure, Theoretical Calculations, and Physicochemical Behavior.

Inorganic chemistry·2026
Same author

Discovery of a tetrazole-thiourea derivative as a potential active agent against multidrug-resistant Staphylococcus aureus and Mycobacterium tuberculosis.

Pharmacological reports : PR·2026
Same author

Linking lipid profile alterations to antibiotic tolerance and natural product synergy in drug-resistant Mycobacterium tuberculosis clinical isolates.

Scientific reports·2026
Same author

Endogenous lipid pneumonia in a brown bear (Ursus arctos).

BMC veterinary research·2026

Related Experiment Video

Updated: Jun 1, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

[Drug resistant tuberculosis].

Zofia Zwolska1, Ewa Augustynowicz-Kopeć

  • 1Instytut GruźIicy i Chorób Płuc w Warszawie, Zakład Mikrobiologii, Krajowe Referencyjne Laboratorium Pratka. z.zwolska@igichp.edu.pl

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|June 17, 2011
PubMed
Summary

Drug-resistant tuberculosis (TB), including multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), is a global health threat. Monitoring drug resistance patterns is crucial for effective TB control and treatment strategies worldwide.

Related Experiment Videos

Last Updated: Jun 1, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Area of Science:

  • Microbiology
  • Epidemiology
  • Public Health

Context:

  • Drug-resistant tuberculosis (TB), particularly multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains, poses a significant global health challenge.
  • High mortality rates, especially in individuals with HIV, underscore the urgency of addressing TB drug resistance.
  • Limited effective chemotherapeutic agents necessitate robust surveillance of Mycobacterium tuberculosis susceptibility patterns.

Purpose:

  • To analyze the prevalence and trends of drug resistance in Mycobacterium tuberculosis isolates.
  • To evaluate the effectiveness of national tuberculosis control programs through the classification of primary and acquired drug resistance.
  • To inform and adjust TB control strategies, including the DOTS-Plus initiative for managing MDR-TB.

Summary:

  • Global surveillance projects initiated by WHO and IUATLD since 1994 have established the worldwide prevalence of MDR-TB.
  • WHO estimates indicate widespread infection with drug-resistant M. tuberculosis strains.
  • Poland has conducted multiple surveys since 1997, monitoring drug resistance in TB patients and observing stable resistance levels with low rates of RMP mono-resistance over 30 years.

Impact:

  • Provides critical data for understanding the epidemiology of TB drug resistance.
  • Highlights the importance of ongoing surveillance for detecting and monitoring MDR and XDR strains.
  • Informs public health policy and treatment guidelines for tuberculosis management, particularly in resource-limited settings.